Cite
HARVARD Citation
Rautenberg, C. et al. (2021). Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1‐mRNA expression in patients with AML and MDS. European journal of haematology. pp. 283-292. [Online].